Focus areas

Focus areas

The Covid CPG is currently organized around planning nine task forces, laying the foundation for a future commission to investigate:

 

  • Origins and prevention, including debates about the origins of this pandemic; analysis of the virus and its variants; and the rising danger of future pandemics
  • Assessment of the danger, including the international network for detection and warning; the state of global biological intelligence and data collection; and how experts assessed the danger as the virus threatened the United States
  • National readiness and the initial response, including the state of pandemic preparedness; efforts to gather medical intelligence; and the initial policy direction to head off the crisis, including travel bans and screening, emergency responses and quarantines, and stockpiles and global supply chains for vital equipment
  • Communities at risk, including how to define the communities at greatest risk and address large gaps in local public health capacities; assessing abilities to detect the spread of the virus and step up to issues of worker safety and business responsibility; and how to engage with communities at risk
  • State and local readiness, containment, and mitigation, including choices about when and how to use lockdowns and mandates and the tools available—or not—to save businesses and jobs, communicate with the public, cope with data problems, conduct testing and contact tracing, and judge when to close and reopen schools
  • Caring for the sick, including those suffering from “Long Covid;” examining the strength and safety of America's institutions; and challenges faced by those on the front lines of primary care, hospitalization, and intensive care
  • Diagnostics, therapeutics, and vaccines—collectively, the promise and challenge of the bio revolution, including the relationship of science, industry, and government in handling the profound opportunities and risks of the bio revolution for dealing with new threats, nationally and globally; the regulatory environment for innovation, and specific issues in R&D and manufacturing, including challenging global production and supply chains for tests, therapeutics, and vaccines; and the challenges in national and global distribution of vaccines
  • Telling the stories of Covid victims and their families and capturing the experiences of those on the frontlines of this crisis, including nurses, doctors, and state and local public health officials
  • Solving data issues, some quite technical, that have impaired the collection and meaningful analysis of information during and about the crisis